See more : ABB India Limited (ABB.NS) Income Statement Analysis – Financial Results
Complete financial analysis of BioInvent International AB (publ) (BOVNF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BioInvent International AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Genor Biopharma Holdings Limited (6998.HK) Income Statement Analysis – Financial Results
- Lida Holdings Limited (4552.TW) Income Statement Analysis – Financial Results
- Four Leaf Acquisition Corporation (FORL) Income Statement Analysis – Financial Results
- NewAge, Inc. (NBEV) Income Statement Analysis – Financial Results
- Lyckegård Group AB (publ) (LYGRD.ST) Income Statement Analysis – Financial Results
BioInvent International AB (publ) (BOVNF)
About BioInvent International AB (publ)
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated myeloid cells; partnership and collaboration with Transgene to co-develskylinop multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck for the clinical development of BI-1808. The Company was incorporated in 1996 and is based in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 71.46M | 326.13M | 19.38M | 147.37M | 93.74M | 38.55M | 45.01M | 71.28M | 15.93M | 46.93M | 81.71M | 42.95M | 124.65M | 82.87M | 80.66M | 252.14M | 143.44M | 50.83M | 28.20M | 58.75M | 66.72M | 87.05M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.88M | 996.00K | 1.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 71.46M | 326.13M | 19.38M | 147.37M | 93.74M | 38.55M | 42.13M | 70.29M | 14.28M | 46.93M | 81.71M | 42.95M | 124.65M | 82.87M | 80.66M | 252.14M | 143.44M | 50.83M | 28.20M | 58.75M | 66.72M | 87.05M |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 93.60% | 98.60% | 89.64% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 390.43M | 325.93M | 258.34M | 191.42M | 207.90M | 140.18M | 109.72M | 99.48M | 80.50M | 73.37M | 71.18M | 207.28M | 163.90M | 178.89M | 229.19M | 215.43M | 140.86M | 120.52M | 122.68M | 126.09M | 131.05M | 111.68M |
| General & Administrative | 51.61M | 50.75M | 39.44M | 32.16M | 29.09M | 27.96M | 39.26M | 35.72M | 31.65M | 31.90M | 30.22M | 39.24M | 163.90M | 32.23M | 35.47M | 30.88M | 28.72M | 260.00K | 256.00K | 30.66M | 36.67M | 37.98M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 31.64M | 28.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 32.56M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 51.61M | 50.75M | 39.44M | 31.64M | 29.09M | 27.96M | 39.26M | 35.72M | 31.65M | 31.90M | 30.22M | 39.24M | 196.46M | 32.23M | 35.47M | 30.88M | 28.72M | 260.00K | 256.00K | 30.66M | 36.67M | 37.98M |
| Other Expenses | -637.00K | -81.00K | -226.00K | -731.00K | -6.25M | -6.50M | -1.62M | -671.00K | -612.00K | -3.42M | -896.00K | -12.20M | -164.06M | -411.00K | -4.49M | -749.00K | -3.54M | 41.98M | 47.51M | 17.00K | -260.00K | -196.00K |
| Operating Expenses | 441.40M | 376.60M | 297.55M | 222.33M | 230.74M | 161.63M | 147.37M | 134.52M | 111.54M | 101.85M | 100.50M | 234.32M | 196.31M | 210.71M | 260.16M | 245.57M | 166.04M | 162.77M | 170.44M | 156.76M | 167.46M | 149.47M |
| Cost & Expenses | 441.40M | 376.60M | 297.55M | 222.33M | 230.74M | 161.63M | 147.37M | 134.52M | 111.54M | 101.85M | 100.50M | 234.32M | 196.31M | 210.71M | 260.16M | 245.57M | 166.04M | 162.77M | 170.44M | 156.76M | 167.46M | 149.47M |
| Interest Income | 40.61M | 9.07M | 264.00K | 28.00K | 65.00K | 103.00K | 130.00K | 34.00K | 63.00K | 589.00K | 684.00K | 3.62M | 4.78M | 989.00K | 3.00M | 9.73M | 34.00K | 2.90M | 2.36M | 87.00K | 57.00K | 69.00K |
| Interest Expense | 638.00K | 650.00K | 517.00K | 336.00K | 482.00K | 6.00K | 4.00K | 9.00K | 2.00K | 1.00K | 0.00 | 9.00K | 169.00K | 1.55M | 163.00K | 53.00K | 7.39M | 10.00K | 18.00K | 5.58M | 11.14M | 16.32M |
| Depreciation & Amortization | 16.76M | 14.72M | 14.61M | 12.00M | 11.61M | 5.06M | 2.88M | 996.00K | 1.65M | 2.04M | 2.90M | 6.14M | 6.31M | 9.37M | 11.12M | 11.54M | 12.31M | 15.42M | 20.30M | 20.96M | 18.87M | 13.48M |
| EBITDA | -312.71M | -27.13M | -263.32M | -63.99M | -126.54M | -118.10M | -97.65M | -61.59M | -93.38M | -51.94M | -15.14M | -182.36M | -60.75M | -117.48M | -165.54M | 27.85M | -4.68M | -93.40M | -119.55M | -71.55M | -148.60M | -135.99M |
| EBITDA Ratio | -437.59% | -8.32% | -1,358.42% | -43.42% | -134.99% | -306.36% | -220.80% | -87.09% | -589.23% | -110.68% | -18.53% | -423.08% | -48.60% | -141.77% | -205.04% | 11.04% | 24.96% | -183.76% | -423.96% | -231.15% | -222.73% | -156.22% |
| Operating Income | -369.94M | -50.92M | -278.35M | -75.47M | -137.85M | -123.23M | -100.63M | -62.86M | -94.97M | -54.93M | -19.18M | -191.09M | -71.66M | -127.84M | -179.50M | 6.57M | 23.45M | -111.73M | -142.33M | -98.10M | 100.75M | 62.42M |
| Operating Income Ratio | -517.68% | -15.61% | -1,435.98% | -51.21% | -147.05% | -319.68% | -223.56% | -88.18% | -596.38% | -117.03% | -23.47% | -444.96% | -57.49% | -154.27% | -222.54% | 2.61% | 16.35% | -219.82% | -504.77% | -166.99% | 151.01% | 71.70% |
| Total Other Income/Expenses | 39.84M | 8.42M | -94.00K | -859.00K | -785.00K | 69.00K | 104.00K | 272.00K | -55.00K | 940.00K | 1.14M | 3.25M | 4.61M | -560.00K | 2.84M | 9.68M | 42.19M | 2.90M | 2.47M | 5.59M | 0.00 | 0.00 |
| Income Before Tax | -330.10M | -42.50M | -278.44M | -76.33M | -138.63M | -123.16M | -100.53M | -62.59M | -95.03M | -53.99M | -18.04M | -187.85M | -67.05M | -128.40M | -176.66M | 16.25M | 16.09M | -108.83M | -139.86M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -461.93% | -13.03% | -1,436.46% | -51.80% | -147.89% | -319.51% | -223.33% | -87.80% | -596.72% | -115.03% | -22.08% | -437.40% | -53.79% | -154.95% | -219.02% | 6.45% | 11.22% | -214.12% | -496.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 204.00K | -8.42M | 517.00K | 336.00K | 482.00K | -72.00K | 86.00K | 159.00K | -4.35M | 933.00K | 752.00K | 3.54M | 4.78M | 989.00K | 3.00M | 261.87M | 221.71M | 3.11M | 2.40M | -64.24M | -257.12M | -195.64M |
| Net Income | -330.30M | -34.09M | -278.96M | -76.67M | -139.12M | -123.16M | -100.53M | -62.59M | -90.68M | -53.99M | -18.04M | -187.85M | -67.05M | -128.40M | -176.66M | 16.25M | -16.09M | -108.83M | -139.86M | -92.52M | 89.66M | 46.17M |
| Net Income Ratio | -462.22% | -10.45% | -1,439.13% | -52.02% | -148.41% | -319.51% | -223.33% | -87.80% | -569.43% | -115.03% | -22.08% | -437.40% | -53.79% | -154.95% | -219.02% | 6.45% | -11.22% | -214.12% | -496.00% | -157.48% | 134.39% | 53.03% |
| EPS | -5.02 | -0.55 | -5.15 | -2.67 | -7.53 | -9.07 | -8.08 | -6.18 | -16.00 | -12.01 | -4.73 | -50.31 | -20.00 | -40.61 | -60.80 | 5.59 | -6.02 | -44.21 | -84.55 | -56.11 | 54.38 | 28.52 |
| EPS Diluted | -5.02 | -0.55 | -5.15 | -2.67 | -7.53 | -8.91 | -8.08 | -6.18 | -15.59 | -12.01 | -4.73 | -50.31 | -20.00 | -40.61 | -60.80 | 5.59 | -6.02 | -44.21 | -84.54 | -56.11 | 54.38 | 28.52 |
| Weighted Avg Shares Out | 65.77M | 61.52M | 54.16M | 28.72M | 18.47M | 13.58M | 12.44M | 10.12M | 5.67M | 4.50M | 3.81M | 3.73M | 3.35M | 3.16M | 2.91M | 2.91M | 2.67M | 2.46M | 1.65M | 1.65M | 1.65M | 1.62M |
| Weighted Avg Shares Out (Dil) | 65.77M | 61.52M | 54.16M | 28.72M | 18.47M | 13.82M | 12.44M | 10.12M | 5.82M | 4.50M | 3.81M | 3.73M | 3.35M | 3.16M | 2.91M | 2.91M | 2.67M | 2.46M | 1.65M | 1.65M | 1.65M | 1.62M |
Source: https://incomestatements.info
Category: Stock Reports